HUM Humana Inc. Common Stock
Sobre Humana Inc. Common Stock Visão geral da empresa da Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
Ler mais
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
HUM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
HUM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 26 de Junho de 2026 | $0,8850 |
| 27 de Março de 2026 | $0,8850 |
| 26 de Dezembro de 2025 | $0,8850 |
| 26 de Setembro de 2025 | $0,8850 |
| 27 de Junho de 2025 | $0,8850 |
| 28 de Março de 2025 | $0,8850 |
| 31 de Dezembro de 2024 | $0,8850 |
| 30 de Setembro de 2024 | $0,8850 |
| 28 de Junho de 2024 | $0,8850 |
| 27 de Março de 2024 | $0,8850 |
| 28 de Dezembro de 2023 | $0,8850 |
| 28 de Setembro de 2023 | $0,8850 |
| 29 de Junho de 2023 | $0,8850 |
| 30 de Março de 2023 | $0,8850 |
| 29 de Dezembro de 2022 | $0,7880 |
| 29 de Setembro de 2022 | $0,7880 |
| 29 de Junho de 2022 | $0,7880 |
| 30 de Março de 2022 | $0,7880 |
| 30 de Dezembro de 2021 | $0,7000 |
| 29 de Setembro de 2021 | $0,7000 |
HUM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 8 24,2%
- Compra 8 24,2%
- Manter 15 45,5%
- Venda 2 6,1%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
23 analistas · 2026-08-19Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $7.61 | $7.29 | 0.32% |
| 31 de Março de 2026 | $10.31 | $10.29 | 0.02% |
| 31 de Dezembro de 2025 | $-3.96 | $-4.05 | 0.09% |
| 30 de Setembro de 2025 | $3.24 | $2.85 | 0.39% |
| 30 de Junho de 2025 | $6.27 | $5.98 | 0.29% |
| 31 de Março de 2025 | $11.58 | $10.17 | 1.4% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Fluxo de Caixa 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Taxas de Crescimento 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Demonstração de Resultados 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Balanço Patrimonial 25
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Fluxo de Caixa 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Avaliação (TTM) 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Margem Operacional % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Lucro líquido | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS Diluído | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Índice de liquidez corrente | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Índice de Liquidez Seca | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $375M | $2.39B | $2.98B | $3.47B | $946M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.050 declarantes · $33.7B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 255 (+143 vs trimestre anterior) | 81 (-80 vs trimestre anterior) | 313 (+42 vs trimestre anterior) | 273 (-45 vs trimestre anterior) | +23.7M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Dodge & Cox | $4.345.737.744 | 10.940.380 | 12,90% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.115.642.737 | 7.843.620 | 9,25% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.311.405.702 | 5.818.956 | 6,86% | Ações |
| STATE STREET CORP | $2.172.441.313 | 5.457.072 | 6,45% | Ações |
| EAGLE CAPITAL MANAGEMENT LLC | $1.528.010.749 | 3.846.762 | 4,54% | Ações |
| Sessa Capital IM, L.P. | $1.480.732.883 | 3.727.740 | 4,40% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.181.074.714 | 2.976.242 | 3,51% | Ações |
| Capital International Investors | $950.462.637 | 2.392.826 | 2,82% | Ações |
| NAYA CAPITAL MANAGEMENT UK LTD | $728.407.339 | 1.833.763 | 2,16% | Ações |
| NORGES BANK | $694.505.009 | 1.748.414 | 2,06% | Ações |
| GOLDMAN SACHS GROUP INC | $659.096.868 | 1.659.274 | 1,96% | Ações |
| FMR LLC | $615.633.048 | 1.549.854 | 1,83% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544.502.820 | 1.370.784 | 1,62% | Ações |
| Capital Research Global Investors | $443.462.035 | 1.116.990 | 1,32% | Ações |
| Slate Path Capital LP | $428.969.795 | 1.079.930 | 1,27% | Ações |
| Capital World Investors | $406.119.738 | 1.022.425 | 1,21% | Ações |
| Newport Trust Company, LLC | $384.768.345 | 968.653 | 1,14% | Ações |
| CITADEL ADVISORS LLC | $363.376.856 | 914.800 | 1,08% | Opção de compra |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348.908.912 | 878.377 | 1,04% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $331.490.508 | 834.526 | 0,98% | Ações |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314.921.577 | 792.814 | 0,93% | Ações |
| CITADEL ADVISORS LLC | $310.904.094 | 782.700 | 0,92% | Opção de venda |
| WELLINGTON MANAGEMENT GROUP LLP | $282.117.958 | 710.231 | 0,84% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $267.791.027 | 674.163 | 0,79% | Ações |
| Maple Rock Capital Partners Inc. | $249.553.862 | 628.251 | 0,74% | Ações |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245.555.446 | 618.185 | 0,73% | Ações |
| GOLDMAN SACHS GROUP INC | $232.333.978 | 584.900 | 0,69% | Opção de compra |
| MARSHALL WACE, LLP | $216.873.381 | 545.978 | 0,64% | Ações |
| CITADEL ADVISORS LLC | $178.080.082 | 448.316 | 0,53% | Ações |
| High Ground Investment Management LLP | $177.941.848 | 447.968 | 0,53% | Ações |
| 1832 Asset Management L.P. | $176.401.430 | 444.090 | 0,52% | Ações |
| BCV Asset Management Inc. | $173.695.656 | 445.719 | 0,52% | Ações |
| BANK OF AMERICA CORP /DE/ | $172.703.708 | 434.781 | 0,51% | Ações |
| Holocene Advisors, LP | $165.040.541 | 415.489 | 0,49% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $147.490.964 | 371.308 | 0,44% | Ações |
| MILLENNIUM MANAGEMENT LLC | $140.098.700 | 352.698 | 0,42% | Ações |
| JANE STREET GROUP, LLC | $137.080.622 | 345.100 | 0,41% | Opção de compra |
| Swiss National Bank | $134.522.525 | 338.660 | 0,40% | Ações |
| JANE STREET GROUP, LLC | $122.542.370 | 308.500 | 0,36% | Opção de venda |
| STEADFAST CAPITAL MANAGEMENT LP | $122.423.204 | 308.200 | 0,36% | Ações |
| BlackRock, Inc. | $120.890.332 | 304.341 | 0,36% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115.565.201 | 290.935 | 0,34% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $109.135.401 | 274.748 | 0,32% | Ações |
| AMERIPRISE FINANCIAL INC | $108.302.217 | 272.614 | 0,32% | Ações |
| Legal & General Group Plc | $103.424.967 | 260.372 | 0,31% | Ações |
| Vanguard Global Advisers, LLC | $103.330.825 | 260.135 | 0,31% | Ações |
| GOLDMAN SACHS GROUP INC | $103.078.590 | 259.500 | 0,31% | Opção de venda |
| NEUBERGER BERMAN GROUP LLC | $102.585.352 | 258.258 | 0,30% | Ações |
| BANK OF NOVA SCOTIA | $102.313.941 | 257.575 | 0,30% | Ações |
| RHUMBLINE ADVISERS | $102.294.748 | 257.527 | 0,30% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $101.464.685 | 255.437 | 0,30% | Ações |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100.979.680 | 254.216 | 0,30% | Ações |
| Gotham Asset Management, LLC | $89.318.889 | 224.860 | 0,27% | Ações |
| Balyasny Asset Management L.P. | $87.965.958 | 221.454 | 0,26% | Ações |
| FIRST TRUST ADVISORS LP | $85.094.587 | 214.226 | 0,25% | Ações |
| Ensign Peak Advisors, Inc | $83.532.585 | 210.293 | 0,25% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83.463.866 | 210.120 | 0,25% | Ações |
| Brandywine Global Investment Management, LLC | $80.388.706 | 313.859 | 0,24% | Ações |
| California Public Employees Retirement System | $80.274.587 | 202.091 | 0,24% | Ações |
| WOLVERINE TRADING, LLC | $76.135.109 | 298.300 | 0,23% | Opção de compra |
| Camber Capital Management LP | $73.344.000 | 300.000 | 0,22% | Ações |
| National Pension Service | $70.860.473 | 178.391 | 0,21% | Ações |
| BARCLAYS PLC | $70.472.788 | 177.415 | 0,21% | Ações |
| Susquehanna Portfolio Strategies, LLC | $69.949.250 | 176.097 | 0,21% | Ações |
| Walleye Trading LLC | $69.473.778 | 174.900 | 0,21% | Opção de compra |
| CANADA PENSION PLAN INVESTMENT BOARD | $68.018.761 | 171.237 | 0,20% | Ações |
| ARGA Investment Management, LP | $66.165.730 | 166.572 | 0,20% | Ações |
| ORBIMED ADVISORS LLC | $65.183.802 | 164.100 | 0,19% | Ações |
| Solel Partners LP | $64.742.888 | 162.990 | 0,19% | Ações |
| AMF Tjanstepension AB | $61.961.951 | 155.989 | 0,18% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60.794.124 | 153.049 | 0,18% | Ações |
| Perpetual Ltd | $57.945.659 | 145.878 | 0,17% | Ações |
| CI INVESTMENTS INC. | $57.302.560 | 144.259 | 0,17% | Ações |
| AMERICAN CENTURY COMPANIES INC | $56.575.256 | 142.426 | 0,17% | Ações |
| Squarepoint Ops LLC | $56.047.742 | 141.100 | 0,17% | Opção de venda |
| Aberdeen Group plc | $53.345.852 | 134.298 | 0,16% | Ações |
| WOLVERINE TRADING, LLC | $52.653.949 | 206.300 | 0,16% | Opção de venda |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52.178.000 | 131.358 | 0,15% | Ações |
| ING GROEP NV | $51.583.784 | 129.862 | 0,15% | Ações |
| Squarepoint Ops LLC | $50.685.272 | 127.600 | 0,15% | Opção de compra |
| Walleye Trading LLC | $49.573.056 | 124.800 | 0,15% | Opção de venda |
| D. E. Shaw & Co., Inc. | $46.514.462 | 117.100 | 0,14% | Opção de compra |
| BRAIDWELL LP | $45.481.690 | 114.500 | 0,14% | Ações |
| Jain Global LLC | $43.694.200 | 110.000 | 0,13% | Opção de venda |
| BANK OF MONTREAL /CAN/ | $43.207.208 | 108.774 | 0,13% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42.190.325 | 106.214 | 0,13% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42.127.167 | 106.055 | 0,13% | Ações |
| AVIVA PLC | $41.509.093 | 104.499 | 0,12% | Ações |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41.468.472 | 161.904 | 0,12% | Ações |
| ROYAL BANK OF CANADA | $41.033.000 | 103.301 | 0,12% | Ações |
| Pentwater Capital Management LP | $39.722.000 | 100.000 | 0,12% | Opção de compra |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39.284.661 | 98.899 | 0,12% | Ações |
| Point72 Asset Management, L.P. | $39.122.595 | 98.491 | 0,12% | Ações |
| PFM Health Sciences, LP | $37.487.638 | 94.375 | 0,11% | Ações |
| Summit Street Capital Management, LLC | $36.325.372 | 91.449 | 0,11% | Ações |
| Columbus Hill Capital Management, L.P. | $35.501.935 | 89.376 | 0,11% | Ações |
| Korea Investment CORP | $34.579.193 | 87.053 | 0,10% | Ações |
| Quantinno Capital Management LP | $32.817.091 | 82.616 | 0,10% | Ações |
| Fisher Funds Management LTD | $32.811.563 | 82.603 | 0,10% | Ações |
| Swedbank AB | $32.034.603 | 80.647 | 0,10% | Ações |
Executivos da empresa 76 insiders · 46 diretores · 27 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 14 de Maio de 2025 P | 30.474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 de Fevereiro de 2024 A | 110.130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 24 de Fevereiro de 2025 A | 29.676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 de Dezembro de 2024 J | 20.165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 de Fevereiro de 2021 A | 24.342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 9 de Maio de 2014 G | 14.916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 27 de Março de 2025 J | 15.702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 24 de Fevereiro de 2025 A | 16.234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 24 de Fevereiro de 2025 A | 11.566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 de Fevereiro de 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 de Dezembro de 2022 M | 3.983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 de Dezembro de 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 de Fevereiro de 2014 A | 105.443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 de Março de 2017 J | 34.668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 24 de Fevereiro de 2025 A | 8.628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 de Fevereiro de 2025 A | 1.767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 24 de Fevereiro de 2025 A | 11.266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 24 de Fevereiro de 2025 A | 17.267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 de Fevereiro de 2025 A | 16.717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 de Dezembro de 2024 G | 7.111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 de Dezembro de 2024 M | 14.015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 de Fevereiro de 2024 A | 11.723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 de Fevereiro de 2023 F | 3.687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 1 de Maio de 2022 M | 4.294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 de Março de 2022 J | 5.723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 de Fevereiro de 2022 F | 6.014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 de Março de 2021 G | 8.168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 de Dezembro de 2019 M | 18.092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 de Dezembro de 2019 M | 6.339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 de Fevereiro de 2019 A | 9.774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 de Fevereiro de 2019 M | 10.791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 de Dezembro de 2018 M | 11.136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 de Dezembro de 2018 M | 6.476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 de Março de 2017 M | 4.361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 de Fevereiro de 2014 A | 1.101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 de Fevereiro de 2014 A | 15.946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 de Junho de 2013 M | 19.347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 de Dezembro de 2012 G | 2.287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 de Abril de 2012 F | 11.946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 de Fevereiro de 2012 A | 23.280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 4 de Fevereiro de 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 de Março de 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 de Fevereiro de 2008 F | 13.836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 de Dezembro de 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 de Fevereiro de 2007 M | 57.548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 6 de Janeiro de 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Conselheiro | 30 de Junho de 2026 A | 19.448 | 0 | 0 | $0 |
| Frank A Damelio | Conselheiro | 2 de Janeiro de 2026 A | 20.634 | 0 | 0 | $0 |
| Karen Katz | Conselheiro | 31 de Dezembro de 2025 A | 590 | 0 | 0 | $0 |
| David T Feinberg | Conselheiro | 30 de Junho de 2025 A | 441 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| David A. Jones ×2 declarações | 12 de Novembro de 2003 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 200 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,29% | 144.763 SH | 8 de Agosto de 2026 | Diário |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,95% | 109.132 NS | 30 de Abril de 2026 | N-PORT |
| SMRI · EA Series Trust | 2,54% | 58.016 NS | 30 de Abril de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,27% | 100.446 SH | 8 de Agosto de 2026 | Diário |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,26% | 2.111 NS | 30 de Abril de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 11.546 SH | 8 de Agosto de 2026 | Diário |
| SRHQ · Elevation Series Trust | 1,63% | 13.322 NS | 30 de Abril de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,60% | 32.564 SH | 8 de Agosto de 2026 | Diário |
| CVAR · ETF Opportunities Trust | 1,51% | 2.473 NS | 30 de Abril de 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,20% | 225 NS | 30 de Abril de 2026 | N-PORT |
| ABCS · EA Series Trust | 1,19% | 441 NS | 29 de Maio de 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,14% | 17.702 NS | 31 de Maio de 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,96% | 17.434 NS | 30 de Abril de 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 52.223 NS | 30 de Abril de 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771.237 SH | 8 de Agosto de 2026 | Diário |
| ITAN · EA Series Trust | 0,77% | 2.259 NS | 29 de Maio de 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,72% | 65.925 NS | 31 de Maio de 2026 | N-PORT |
| IYH · iShares Trust | 0,72% | 71.884 SH | 8 de Agosto de 2026 | Diário |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 183.164 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,70% | 360.880 SH | 8 de Agosto de 2026 | Diário |
| AUSF · Global X Funds | 0,70% | 19.401 NS | 31 de Maio de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,63% | 211 NS | 31 de Maio de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,59% | 30.459 NS | 30 de Abril de 2026 | N-PORT |
| IXJ · iShares Trust | 0,56% | 62.953 SH | 8 de Agosto de 2026 | Diário |
| RXL · ProShares Trust | 0,53% | 1.258 NS | 31 de Maio de 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 2.755 NS | 30 de Abril de 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2.601.869 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 55.439 NS | 30 de Abril de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,45% | 28.340 NS | 30 de Abril de 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,43% | 3.849 NS | 29 de Maio de 2026 | N-PORT |
| IWS · iShares Trust | 0,42% | 181.221 SH | 8 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,41% | 2.404 NS | 30 de Abril de 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,37% | 81 NS | 31 de Maio de 2026 | N-PORT |
| IMCV · iShares Trust | 0,36% | 11.394 SH | 8 de Agosto de 2026 | Diário |
| QARP · DBX ETF Trust | 0,36% | 887 NS | 29 de Maio de 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,35% | 10.520.000 | 8 de Agosto de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,35% | 90.057 SH | 8 de Agosto de 2026 | Diário |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,34% | 4.484 NS | 31 de Maio de 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,34% | 1.004 NS | 31 de Maio de 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,32% | 265.500 NS | 31 de Maio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 7.839 SH | 8 de Agosto de 2026 | Diário |
| IWR · iShares Trust | 0,32% | 489.015 SH | 8 de Agosto de 2026 | Diário |
| IMCB · iShares Trust | 0,30% | 13.840 SH | 8 de Agosto de 2026 | Diário |
| FNDB · SCHWAB STRATEGIC TRUST | 0,29% | 12.439 NS | 31 de Maio de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,29% | 2.779 NS | 30 de Abril de 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,28% | 1.250 NS | 31 de Maio de 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 320.000 | 8 de Agosto de 2026 | Diário |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,27% | 299 NS | 31 de Maio de 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,26% | 12.272 NS | 30 de Abril de 2026 | N-PORT |
| VLUE · iShares Trust | 0,24% | 62.558 SH | 8 de Agosto de 2026 | Diário |